Xenon Pharmaceuticals Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 14.31M27.36M28.37M15.58M1.80M0.31M-1.39M6.83M32.17M18.44M9.43M
Gross Profit 14.31M27.36M28.37M15.58M1.80M0.31M-1.39M6.83M32.17M18.44M9.43M
Operating items
Research & Development 10.46M12.30M11.77M15.15M19.83M25.57M23.63M38.84M50.52M75.46M105.77M167.51M210.39M
Selling, General & Administrative 7.01M5.34M5.50M9.79M6.79M7.31M8.41M10.80M12.94M21.97M32.81M46.54M68.90M
Restructuring Costs 10.00M14.38M20.66M
Other Operating Expenses -1.03M0.01M4.40M-10.00M-14.38M-20.66M
Operating Expenses 17.46M17.64M17.26M24.94M26.62M32.89M38.04M49.65M63.47M97.43M138.58M214.05M279.30M
Operating Income -3.15M9.71M11.11M-9.36M-24.82M-32.58M-38.04M-42.82M-31.30M-78.99M-129.14M-214.05M-279.30M
EBIT -3.15M9.71M11.11M-9.36M-24.82M-32.58M-38.04M-42.82M-31.30M-78.99M-129.14M-214.05M-279.30M
Non-operating items
Non Operating Investment Income 0.00M-0.72M
Interest & Investment Income 0.14M0.34M0.57M0.54M0.50M0.48M1.22M2.35M2.28M0.47M8.71M27.62M41.94M
Other Non Operating Income -0.17M2.04M1.34M-6.93M1.32M1.39M-0.70M0.48M1.40M2.03M-1.89M0.20M-1.06M
Non Operating Income 2.21M0.10M3.89M31.37M40.88M
Net income details
EBT -3.10M9.99M11.67M-8.82M-24.31M-32.12M-34.52M-41.62M-29.09M-78.89M-125.25M-182.69M-243.41M
Tax Provisions -0.02M-0.02M-0.26M-0.01M0.16M-0.29M4.78M
Profit After Tax -4.30M12.03M13.02M-15.75M-23.00M-30.70M-34.50M-41.59M-28.84M-78.88M-125.37M-182.39M-234.33M
Income from Continuing Operations -3.10M9.99M11.67M-8.82M-24.31M-32.12M-34.50M-41.59M-28.84M-78.88M-125.42M-182.39M-248.19M
Consolidated Net Income -3.10M9.99M11.67M-8.82M-24.31M-32.12M-34.50M-41.59M-28.84M-78.88M-125.42M-182.39M-248.19M
Income towards Parent Company -3.10M9.99M11.67M-8.82M-24.31M-32.12M-34.50M-41.59M-28.84M-78.88M-125.42M-182.39M-248.19M
Preferred Dividend Payments 8.20M2.88M1.57M0.82M1.79M0.44M
Net Income towards Common Stockholders -4.30M3.83M13.02M-15.75M-24.31M-30.70M-31.62M-40.03M-28.01M-77.09M-124.94M-182.39M-234.33M
Additional items
EPS (Basic) -0.00M0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 14.18M14.38M17.89M18.00M25.24M25.87M35.01M51.59M62.54M65.43M76.24M
Shares Outstanding (Diluted Average) 1.33M2.01M3.96M14.28M15.49M34.54M43.63M60.54M66.89M77.89M
EBITDA -3.15M10.80M9.52M-15.75M-23.00M-32.58M-38.04M-42.82M-31.30M-78.99M-129.14M-214.05M-279.30M
Shares Outstanding 4.32M4.32M14.18M14.39M17.93M18.00M28.14M35.01M51.63M62.59M75.37M76.42M
Tax Rate 0.00M0.00M0.00M0.00M0.00M